Philip Morris International (PM) said the FDA issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of its ZYN nicotine pouch products, the first authorization of nicotine pouches under the MRTP framework. The regulatory milestone should strengthen ZYN’s competitive position and support longer-run demand visibility for PM.
Philip Morris International (PM) said the FDA issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of its ZYN nicotine pouch products, the first authorization of nicotine pouches under the MRTP framework. The regulatory milestone should strengthen ZYN’s competitive position and support longer-run demand visibility for PM.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.55
Ticker Sentiment
